BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23580348)

  • 1. Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signaling.
    Singh T; Katiyar SK
    PLoS One; 2013; 8(4):e60749. PubMed ID: 23580348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
    Singh T; Katiyar SK
    Int J Oncol; 2011 Mar; 38(3):769-76. PubMed ID: 21225228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial Note: Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by Targeting PGE2-Mediated Activation of β-Catenin Signaling.
    PLOS ONE Editors
    PLoS One; 2024; 19(5):e0303600. PubMed ID: 38739616
    [No Abstract]   [Full Text] [Related]  

  • 4. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
    Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
    Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE
    Che D; Zhang S; Jing Z; Shang L; Jin S; Liu F; Shen J; Li Y; Hu J; Meng Q; Yu Y
    Mol Immunol; 2017 Oct; 90():197-210. PubMed ID: 28837884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silymarin targets β-catenin signaling in blocking migration/invasion of human melanoma cells.
    Vaid M; Prasad R; Sun Q; Katiyar SK
    PLoS One; 2011; 6(7):e23000. PubMed ID: 21829575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib potentially inhibits metastasis of lung cancer promoted by surgery in mice, via suppression of the PGE2-modulated β-catenin pathway.
    Zhang S; Da L; Yang X; Feng D; Yin R; Li M; Zhang Z; Jiang F; Xu L
    Toxicol Lett; 2014 Mar; 225(2):201-7. PubMed ID: 24374173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition.
    Singh T; Katiyar SK
    PLoS One; 2011; 6(10):e25224. PubMed ID: 22022384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
    Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J
    Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo.
    Singh T; Prasad R; Katiyar SK
    Epigenetics; 2013 Jan; 8(1):54-65. PubMed ID: 23221619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK; Wan CK; Shen XL; Yang M; Fong WF
    Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
    Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.
    Hua H; Chen W; Shen L; Sheng Q; Teng L
    Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):773-9. PubMed ID: 23786838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP.
    Lv XQ; Qiao XR; Su L; Chen SZ
    Acta Pharmacol Sin; 2016 Dec; 37(12):1574-1586. PubMed ID: 27593221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting H19 by lentivirus-mediated RNA interference increases A549 cell migration and invasion.
    Wang L; Sun Y; Yi J; Wang X; Liang J; Pan Z; Li L; Jiang G
    Exp Lung Res; 2016 Sep; 42(7):346-353. PubMed ID: 27607135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
    Geng F; Jiang Z; Song X; Zhou H; Zhao H
    Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
    Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
    Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DKK1 promotes migration and invasion of non-small cell lung cancer via β-catenin signaling pathway.
    Zhang J; Zhang X; Zhao X; Jiang M; Gu M; Wang Z; Yue W
    Tumour Biol; 2017 Jul; 39(7):1010428317703820. PubMed ID: 28677426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway.
    You J; Cheng J; Yu B; Duan C; Peng J
    Med Sci Monit; 2018 Apr; 24():2126-2133. PubMed ID: 29632297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.